StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) bonds

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$698.47+8.23 (+1.19%)

Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$449.86M
$150.00M due within a year
Net debt
$252.93M
After $196.93M of cash
Implied interest rate
7.28%
FY2025 interest ÷ average debt
Interest coverage
35.0×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in IDEXX Laboratories's 10-Q for the period ended Jun 30, 2026

IssueCouponMaturesAmount issued
2026 Senior Notes3.72%2026$75.00M
2021 Series A Notes3.32%–$50.00M
2021 Series A Notes and 2024 Series B Notes––$125.00M
2022 Series A Notes3.25%–$75.00M
2022 Series A Notes and 2027 Series B Notes––$150.00M
2023 Series A Notes3.94%–$75.00M
2023 Series A Notes and 2025 Series B Notes––$150.00M
2024 Series B Notes3.76%–$75.00M
2025 Series B Notes4.04%–$75.00M
2025 Series C Notes1.79%–€88.90M
2027 Series B Notes3.72%–$75.00M
2029 Series C Notes4.19%–$100.00M
MetLife 2030 Series D Notes2.50%–$125.00M
Prudential 2030 Series D Notes2.50%–$75.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeAvailable
Revolving Credit Facility$1.25B$729.20M
Revolving Credit Facility––
Term Loan$250.00M–
Term Loan––

See a number that looks wrong?